LALPATHLAB

Dr. Lal Pathlabs Share PriceDr. Lal Pathlabs

₹2,669.00
21.45 (0.81%)
  • Advice
  • Hold
As on 30 November, 2023 | 06:44 BSE: 539524 NSE: LALPATHLABISIN: INE600L01024

Dr. Lal Pathlabs Performance

Day Range

  • Low 2,642.55
  • High 2,685.75
₹ 2,669.00

52 Week Range

  • Low 1,762.05
  • High 2,767.10
₹ 2,669.00
  • Open Price2,652.80
  • Previous Close2,647.55
  • Volume189857

Start SIP in Dr. Lal Pathlabs

Start SIP

Dr. Lal Pathlabs Share Price

  • Over 1 Month 12.95%
  • Over 3 Month 22.91%
  • Over 6 Month 30.47%
  • Over 1 Year 10.57%

Dr. Lal Pathlabs Key Statistics

P/E Ratio 73.9
PEG Ratio 3.4
Market Cap Cr 22,280
Price to Book Ratio 13.1
EPS 34.9
Dividend 0.4
Relative Strength Index 56.44
Money Flow Index 53.94
MACD Signal 57.09
Average True Range 75.92

Dr. Lal Pathlabs Investment Rating

  • Master Rating:
  • Dr Lal Pathlabs has an operating revenue of Rs. 2,122.70 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 17% is great, ROE of 14% is good. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 21% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Services and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Dr. Lal Pathlabs Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 532480431428467439415
Operating Expenses Qtr Cr 369344315324337330310
Operating Profit Qtr Cr 163136116104130109105
Depreciation Qtr Cr 19182121211922
Interest Qtr Cr 778810811
Tax Qtr Cr 38322722282220
Net Profit Qtr Cr 113947162798065
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1,8161,926
Operating Expenses Annual Cr 1,3081,362
Operating Profit Annual in Cr 461510
Depreciation Cr 8275
Interest Annual Cr 3429
Tax Annual Cr 98115
Net Profit Annual Cr 292344
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 428424
Cash from Investing Activity Annual Cr -288-449
Cash from Financing Annual Activity Cr -270142
Net Cash Flow Annual Cr -131117
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,6901,476
Fixed Assets Annual Cr 366385
Total Non Current Assets Annual Cr 1,5101,518
Total Current Assets Annual Cr 810696
Total Assets Annual Cr 2,3202,214
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 203177
ROE Annual % 1723
ROCE Annual % 2328
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2930
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 601541491489534503486
Operating Expenses Qtr Cr 424395375376390385364
Operating Profit Qtr Cr 178146116113144118121
Depreciation Qtr Cr 36353838393638
Interest Qtr Cr 889911912
Tax Qtr Cr 42342623302321
Net Profit Qtr Cr 109835753725861
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 2,0592,140
Operating Expenses Annual Cr 1,5271,527
Operating Profit Annual in Cr 490561
Depreciation Cr 150108
Interest Annual Cr 3830
Tax Annual Cr 103125
Net Profit Annual Cr 239345
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 456447
Cash from Investing Activity Annual Cr -287-449
Cash from Financing Annual Activity Cr -283136
Net Cash Flow Annual Cr -114134
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1,6661,508
Fixed Assets Annual Cr 762840
Total Non Current Assets Annual Cr 1,4121,478
Total Current Assets Annual Cr 973875
Total Assets Annual Cr 2,3862,353
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 204185
ROE Annual % 1423
ROCE Annual % 2027
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2629

Dr. Lal Pathlabs Technicals

EMA & SMA

Current Price
₹2,669.00
21.45 (0.81%)
pointer
  • Bullish Moving Average
  • ___
  • 15
  • Bearish Moving Average
  • ___
  • 1
  • 20 Day
  • ₹2,630.63
  • 50 Day
  • ₹2,532.79
  • 100 Day
  • ₹2,422.48
  • 200 Day
  • ₹2,335.85
  • 20 Day
  • ₹2,643.93
  • 50 Day
  • ₹2,525.43
  • 100 Day
  • ₹2,412.10
  • 200 Day
  • ₹2,190.18

Dr. Lal Pathlabs Resistance and Support

PIVOT
₹2,665.77
Resistance
First Resistance 2,688.98
Second Resistance 2,708.97
Third Resistance 2,732.18
RSI 56.44
MFI 53.94
MACD Single Line 57.09
MACD 48.86
Support
First Resistance 2,645.78
Second Resistance 2,622.57
Third Resistance 2,602.58

Dr. Lal Pathlabs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 191,330 11,558,245 60.41
Week 289,456 11,725,852 40.51
1 Month 346,970 12,126,595 34.95
6 Month 278,787 10,315,106 37

Dr. Lal Pathlabs Result Highlights

Dr. Lal Pathlabs Synopsis

NSE-Medical-Services

Dr. Lal Pathlabs Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 1769.03 Cr. and Equity Capital is Rs. 83.37 Cr. for the Year ended 31/03/2023. Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388.
Market Cap 22,280
Sales 1,871
Shares in Float 3.76
No of funds 290
Yield 0.45
Book Value 13.17
U/D Vol ratio 1.9
LTDebt / Equity 5
Alpha 0.03
Beta 0.68

Dr. Lal Pathlabs

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 54.61%55.01%55.03%55.05%
Mutual Funds 5.36%4.92%3.26%2.71%
Insurance Companies 2.61%2.41%2.28%2.37%
Foreign Portfolio Investors 24.35%23.27%23.06%23.8%
Financial Institutions/ Banks
Individual Investors 8.37%9.31%9.5%9.02%
Others 4.7%5.08%6.87%7.05%

Dr. Lal Pathlabs Management

Name Designation
Brig.(Hony) Dr. Arvind Lal Executive Chairman
Dr. Om Prakash Manchanda Managing Director
Dr. Vandana Lal Executive Director
Mr. Rahul Sharma Non Executive Director
Dr. Archana Lal Erdmann Non Executive Director
Mr. Sunil Varma Lead Independent Director
Mr. Anoop Mahendra Singh Independent Director
Mr. Harneet Singh Chandhoke Independent Director
Dr. Saurabh Srivastava Independent Director
Mrs. Somya Satsangi Independent Director
Mr. Rohit Bhasin Independent Director
Mr. Arun Duggal Independent Director
Mr. Gurinder Singh Kalra Independent Director
Mr. Rajit Mehta Independent Director

Dr. Lal Pathlabs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Dr. Lal Pathlabs Corporate Action

Date Purpose Remarks
2023-11-02 Quarterly Results
2023-07-27 Quarterly Results & Interim Dividend
2023-05-11 Audited Results & Final Dividend
2023-02-02 Quarterly Results
2022-11-08 Quarterly Results
Date Purpose Remarks
2023-08-11 FINAL Rs.6.00 per share(60%)Final Dividend
2023-08-11 INTERIM Rs.6.00 per share(60%)Interim Dividend
2022-08-09 INTERIM Rs.6.00 per share(60%)Interim Dividend
2022-06-23 FINAL Rs.6.00 per share(60%)Final Dividend
2021-08-22 INTERIM Rs.6.00 per share(60%)Interim Dividend

Dr. Lal Pathlabs MF Shareholding

Name Amount(cr)
Kotak Equity Arbitrage Fund Growth 28,958
UTI Flexi Cap Fund Regular Plan Growth 24,370
SBI Arbitrage Opportunities Fund Regular Growth 22,370
Canara Robeco Emerging Equities Growth 17,563
SBI Large & Midcap Fund Regular Payout Inc Dist cum Cap Wdrl 15,649

Dr. Lal Pathlabs FAQs

What is Share Price of Dr. Lal Pathlabs ?

Dr. Lal Pathlabs share price is ₹2,669 As on 30 November, 2023 | 06:30

What is the Market Cap of Dr. Lal Pathlabs ?

The Market Cap of Dr. Lal Pathlabs is ₹22280.3 Cr As on 30 November, 2023 | 06:30

What is the P/E ratio of Dr. Lal Pathlabs ?

The P/E ratio of Dr. Lal Pathlabs is 73.9 As on 30 November, 2023 | 06:30

What is the PB ratio of Dr. Lal Pathlabs ?

The PB ratio of Dr. Lal Pathlabs is 13.1 As on 30 November, 2023 | 06:30

Q2FY23